Cannabinoid Biosynthesis Market - Top Companies and Manufacturers

  • Report ID: 4142
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Companies Dominating the Cannabinoid Biosynthesis Landscape

top-features-companies
    • Amyris, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Willow Bioscience Inc.
    • Cronos Group
    • Zymergen Inc.
    • Constellation Brands, Inc.
    • Jazz Pharmaceuticals plc
    • Canopy Growth Corporation
    • InMed Pharmaceuticals Inc.
    • Hyasynth Biologicals Inc.
    • Renew Biopharma, Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Trulieve Cannabis Corp. completed the acquisition of Harvest Health & Recreation, this merger is to create the largest chain of marijuana company in the United States by opening 149 dispensaries and operation in 11 states.

  • Jazz Pharmaceuticals announced the acquisition of GW Pharmaceuticals plc, a leading player of science and development of cannabis-based medicine. With the purchase of GW, the commercial portfolio of Jazz Pharmaceuticals is to introduced diversity in medicine


Author Credits:  Radhika Pawar


  • Report ID: 4142
  • Published Date: Jul 25, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of cannabinoid biosynthesis is evaluated at USD 22.63 Billion.

The cannabinoid biosynthesis market size was valued at USD 19.75 Billion in 2023 and is projected to exceed USD 139.1 Billion by the end of 2036, registering over 16.2% CAGR during the forecast period i.e., between 2024-2036. Increasing sales of cannabis-based products, rise in the partnership among the companies, higher legalization of cannabis use for adults, and rising use of cannabis for medical purposes are the major factors driving the market growth.

Asia Pacific is anticipated to account for majority industry share by 2036, attributed to increasing cases of depression and anxiety that are rapidly expanding the use of medical marijuana.

Amyris, Inc., Willow Bioscience Inc., Cronos Group, Zymergen Inc., Constellation Brands, Inc., Jazz Pharmaceuticals plc, Canopy Growth Corporation, InMed Pharmaceuticals Inc., Hyasynth Biologicals Inc., Renew Biopharma, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying